140 related articles for article (PubMed ID: 36621225)
1. Neuralgic Amyotrophy After COVID-19 Vaccination in an Adolescent: Successful Intravenous Immunoglobulin Treatment.
Fukahori K; Saito N; Abe Y; Ikuse T; Tohyama J; Saitoh A
Pediatr Neurol; 2023 Mar; 140():50-51. PubMed ID: 36621225
[No Abstract] [Full Text] [Related]
2. Rapid resolution of severe neuralgic amyotrophy after treatment with corticosteroids and intravenous immunoglobulin.
Johnson NE; Petraglia AL; Huang JH; Logigian EL
Muscle Nerve; 2011 Aug; 44(2):304-5. PubMed ID: 21717467
[No Abstract] [Full Text] [Related]
3. Painless idiopathic neuralgic amyotrophy after COVID-19 vaccination: A case report.
Diaz-Segarra N; Edmond A; Gilbert C; Mckay O; Kloepping C; Yonclas P
PM R; 2022 Jul; 14(7):889-891. PubMed ID: 33886164
[No Abstract] [Full Text] [Related]
4. Neuralgic amyotrophy following COVID-19 mRNA vaccination.
Koh JS; Goh Y; Tan BY; Hui AC; Hoe RHM; Makmur A; Kei PL; Vijayan J; Ng KWP; Quek AML; Thirugnanm U
QJM; 2021 Nov; 114(7):503-505. PubMed ID: 34347105
[No Abstract] [Full Text] [Related]
5. Neuralgic Amyotrophy After ChAdOx1 nCoV-19 COVID-19 Vaccination.
James J; Johnson J; Jose J
J Clin Neuromuscul Dis; 2022 Dec; 24(2):112-113. PubMed ID: 36409345
[No Abstract] [Full Text] [Related]
6. Leg paralysis after AstraZeneca COVID-19 vaccination diagnosed as neuralgic amyotrophy of the lumbosacral plexus: a case report.
Kim SI; Seok HY; Yi J; Cho JH
J Int Med Res; 2021 Nov; 49(11):3000605211056783. PubMed ID: 34816739
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin (IVIg) with methylprednisolone pulse therapy for motor impairment of neuralgic amyotrophy: clinical observations in 10 cases.
Naito KS; Fukushima K; Suzuki S; Kuwahara M; Morita H; Kusunoki S; Ikeda S
Intern Med; 2012; 51(12):1493-500. PubMed ID: 22728480
[TBL] [Abstract][Full Text] [Related]
8. Associations of neuralgic amyotrophy with COVID-19 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.
Kim JE; Park J; Min YG; Hong YH; Song TJ
Muscle Nerve; 2022 Dec; 66(6):766-770. PubMed ID: 36214181
[TBL] [Abstract][Full Text] [Related]
9. Answer to Cabona et al « Isolated musculocutaneous nerve involvement in COVID-19 related Neuralgic amyotrophy» Joint Bone Spine 2021;88:105238 and to Finsterer and Scorza « SARS-CoV-2 or SARS-CoV-2 vaccination associated Parsonage-Turner syndrome». Joint Bone Spine 2021;88:105239.
Coll C; Tessier M; Vandendries C; Seror P
Joint Bone Spine; 2021 Dec; 88(6):105240. PubMed ID: 34146696
[No Abstract] [Full Text] [Related]
10. Chronic Brachial Plexus Neuritis That Developed into Typical Neuralgic Amyotrophy and Positively Responded to Immunotherapy.
Morishima R; Nagaoka U; Nagao M; Isozaki E
Intern Med; 2018 Apr; 57(7):1021-1026. PubMed ID: 29269655
[TBL] [Abstract][Full Text] [Related]
11. Diaphragmatic Dysfunction due to Neuralgic Amyotrophy After SARS-CoV-2 Vaccination: A Case Report.
Kang J; Cho JY
J Korean Med Sci; 2022 Oct; 37(38):e283. PubMed ID: 36193639
[TBL] [Abstract][Full Text] [Related]
12. [Pathogenesis and treatment of brachial plexus neuritis].
Ikeda S
Rinsho Shinkeigaku; 2013; 53(11):969-73. PubMed ID: 24291849
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 or SARS-CoV-2 vaccination associated Parsonage-Turner syndrome. Comment on: "Neuralgic amyotrophy and COVID-19 infection: 2 cases of spinal accessory nerve palsy" by Coll et al. Joint Bone Spine 2021;88:105196.
Finsterer J; Scorza FA
Joint Bone Spine; 2021 Dec; 88(6):105239. PubMed ID: 34139321
[No Abstract] [Full Text] [Related]
14. Four cases of anti-ganglioside antibody-positive neuralgic amyotrophy with good response to intravenous immunoglobulin infusion therapy.
Moriguchi K; Miyamoto K; Takada K; Kusunoki S
J Neuroimmunol; 2011 Sep; 238(1-2):107-9. PubMed ID: 21872943
[TBL] [Abstract][Full Text] [Related]
15. Neuralgic amyotrophy in COVID-19 infection and after vaccination.
Ng GJ; Chiew YR; Kong Y; Koh JS
Ann Acad Med Singap; 2022 Jun; 51(6):376-377. PubMed ID: 35786759
[No Abstract] [Full Text] [Related]
16. Isolated musculocutaneous nerve involvement in COVID-19 related Neuralgic amyotrophy. Comment on: "Neuralgic amyotrophy and COVID-19 infection: 2 cases of spinal accessory nerve palsy" by Coll et al. Joint Bone Spine 2021;88:105196.
Cabona C; Zaottini F; Pistoia F; Grisanti S; Schenone C; Villani F; Schenone A; Aloé T; Reni L; Benedetti L
Joint Bone Spine; 2021 Dec; 88(6):105238. PubMed ID: 34126255
[No Abstract] [Full Text] [Related]
17. Isolated musculocutaneous involvement in neuralgic amyotrophy associated with SARS-CoV2 vaccination.
Civardi C; Delconte C; Pisano F; Collini A; Geda C
Neurol Sci; 2022 Jun; 43(6):3515-3517. PubMed ID: 35290535
[No Abstract] [Full Text] [Related]
18. [Neuralgic amyotrophy].
Dedaev SI; Druzhinina ES; Druzhinin DS; Tumurov DA; Ilyasov SV
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(1):8-14. PubMed ID: 35175697
[TBL] [Abstract][Full Text] [Related]
19. Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis).
van Alfen N; van Engelen BG; Hughes RA
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD006976. PubMed ID: 19588414
[TBL] [Abstract][Full Text] [Related]
20. Extended Neuralgic Amyotrophy Syndrome in a Confirmed COVID-19 Patient After Intensive Care Unit and Inpatient Rehabilitation Stay.
Alvarez A; Amirianfar E; Mason MC; Huang L; Jose J; Tiu T
Am J Phys Med Rehabil; 2021 Aug; 100(8):733-736. PubMed ID: 34001839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
